Figure 1From: Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells Inhibition of cell growth by ACR and LY294002 in HLF human HCC cells and Hc normal hepatocytes. HLF and Hc cells were treated with the indicated concentrations of ACR (A) or LY294002 (B) for 48 hours. Cell viability was determined by the MTS assay and expressed as a percentage of the control value. Error bars present the SD of triplicate assays.Back to article page